Twist Bioscience climbs after raising 2024 revenue forecast
** Shares of synthetic biology co Twist Bioscience TWST.O
rise ~6.2% to $35.51 in early trading
** Co forecasts annual revenue between $288 mln to $293 mln,
compared with its previous expectation of $285 mln to $290 mln
** TWST's quarterly revenue of $71.50 mln beats analysts'
average expectation of $67.60 mln - LSEG data
** Including session's move, stock up 7.6% in the last 12
months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))